drugset / Trial / NCT07568015
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
RandomizedParallel-groupSingle-blindTreatment
Summary
The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2027-11-01
- Completion
- 2029-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Triamcinolone | Other / unclassified | 40 mg | Other |
Indications
No indication recorded.